Diphenyl diselenide alone and in combination with itraconazole against Sporothrix schenckii s.str. and Sporothrix globosa

被引:0
作者
Vanice Rodrigues Poester
Lívia Silveira Munhoz
Cristina Wayne Nogueira
Gilson Rogério Zeni
David A. Stevens
Melissa Orzechowski Xavier
机构
[1] Universidade Federal Do Rio Grande (FURG),Programa de Pós Graduação em Ciências da Saúde, Laboratório de Micologia, Faculdade de Medicina (FAMED)
[2] Universidade Federal de Santa Maria (UFSM),Programa de Pós Graduação em Bioquímica Toxicológica
[3] California Institute for Medical Research,Div. of Infectious Diseases and Geographic Medicine
[4] Stanford University Medical School,undefined
来源
Brazilian Journal of Microbiology | 2021年 / 52卷
关键词
Antifungal activity; Sporotrichosis; Organoselenium compound; Subcutaneous mycoses;
D O I
暂无
中图分类号
学科分类号
摘要
We evaluated the in vitro susceptibility of Sporothrix schenckii s.str. and Sporothrix globosa to diphenyl diselenide (PhSe)2 alone and in association with itraconazole (ITZ). Eight clinical isolates were tested in microdilution and checkerboard assays. (PhSe)2 alone inhibited all isolates in concentration ≤ 8 µg/mL and was effective in killing one S. schenckii isolate. Inhibitory and fungicidal beneficial effects in its interaction with ITZ were shown against 87.5% (7/8) and 50% (4/8) of the isolates tested, respectively. Our study demonstrates the in vitro antifungal activity of (PhSe)2 against two pathogenic Sporothrix species, suggesting studies of in vivo applications are warranted.
引用
收藏
页码:1271 / 1274
页数:3
相关论文
共 60 条
  • [1] Chakrabarti A(2015)Global epidemiology of sporotrichosis Med Mycol 53 3-14
  • [2] Bonifaz A(2008)Epidemic sporotrichosis Curr Opin Infect Dis 21 129-133
  • [3] Gutierrez-Galhardo MC(2017)Origin and distribution of J Med Microbiol 66 560-569
  • [4] Mochizuki T(2011) causing sapronoses in Asia Clin Infect Dis 52 200-206
  • [5] Li S(2016)Treatment of cutaneous sporotrichosis with itraconazole-study of 645 patients Am J Trop Med Hyg 94 1218-1222
  • [6] Schubach A(2018)Atypical clinical presentation of sporotrichosis caused by Med Mycol Case Rep 19 18-20
  • [7] Barros MB(2011) resistant to itraconazole Mycoses 54 572-576
  • [8] Wanke B(2016)Sporotrichosis by Med Mycol 54 550-555
  • [9] Moussa TAA(2017)sensostricto with itraconazole resistance and terbinafine sensitivity observed Antimicrob Agents Chemother 61 e01057-17
  • [10] Kadasa NMS(2015) and PLoS Negl Trop Dis 9 e0004190-387